Lessons from the two Korean Supreme Court decisions concerning AstraZeneca’s Forxiga

Korean Supreme Court decisions on AstraZeneca's Forxiga patents highlight legal complexities involving Doctrine of Equivalents and inventiveness, influencing patent protection dynamics in the pharmaceutical sector in Korea.

March 2023, Managing IP